How to Buy Aligos Therapeutics Stock

Aligos Therapeutics Inc

Aligos Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases.

Aligos Therapeutics stock last closed at $4.62, down 1.28% from the previous day, and has decreased 76.93% in one year. It has overperformed other stocks in the Biotechnology industry by 0.01 percentage points. Aligos Therapeutics stock is currently +22.87% from its 52-week low of $3.76, and -90.13% from its 52-week high of $46.80.

At the moment, there are 6.11M ALGS shares outstanding. The market cap of ALGS is $28.25M. In the past 24 hours, 111,356 ALGS shares were traded.

How to Buy Aligos Therapeutics Stock

Not sure how to invest in Aligos Therapeutics stock? Here's how.

  1. Figure out where to buy Aligos Therapeutics stock: You need to pick an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you determine where to buy Aligos Therapeutics stock.
  2. Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Fund your investment account: Select your payment method and add your information.
  4. Evaluate Aligos Therapeutics stock: The Aligos Therapeutics ticker symbol is ALGS. Is Aligos Therapeutics stock a good investment? Should you buy shares of ALGS? How do ALGS's underlying business fundamentals look? Do top analysts think Aligos Therapeutics is a good buy? Why has ALGS's stock price moved recently? (Hint: Our stock research tools can help you figure out if ALGS is a good stock to buy).
  5. Make your ALGS purchase: Decide if you will purchase ALGS shares at the current market price or use a limit order to buy ALGS shares at a given price.
  6. Get the latest scoop on your ALGS investment: Create a watchlist to get live updates on your new investment in Aligos Therapeutics shares.

Step 1: Figure out where to buy Aligos Therapeutics stock

You need an online brokerage account to access the NASDAQ market and buy ALGS stock.

A brokerage account is an investment account that enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our experience, eToro is the best place to buy stocks. Here's why:

  • You can invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to world financial markets: From Technology to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
  • Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've chosen the right brokerage, the next step is to fill out some personal information so you can invest in ALGS today.

How to Start a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal data to open a new brokerage account.
  1. Submit your info by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your investment account

Now that you have created your account on a mobile trading app, you need to deposit funds:

Check out the walkthrough below to see the process of depositing funds into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Aligos Therapeutics stock

After you have identified the best place to buy Aligos Therapeutics stock, it's critical to research their stock before you buy, so you truly wrap your head around the risk and upside.

Aligos Therapeutics Metrics

ALGS Price
$4.62
1w %
0.22%
1y %
-76.93%
5y %
N/A
P/E
-0.22x
P/B
-0.97x
P/S
7.33x
PEG
N/A
Revenue
$3.95M
Earnings
-$131.21M
Fore. Rev. Growth
187.85%
Fore. Earn. Growth
N/A
Market Cap
$28.25M
Next Earnings
May 5, 2025
Next Dividend
N/A

ALGS Due Diligence Score

WallStreetZen was created to help everyday investors perform better fundamental analysis in minutes instead of hours.

You can view all of the due diligence checks on ALGS's stock page.

Is ALGS stock overvalued?

Investors use many financial metrics, analyses, models, and charts to gauge ALGS's intrinsic value.

You can do additional valuation research on ALGS's stock here.

ALGS Financial Summary

Signs that ALGS is financially healthy:

  • ALGS has $57.05M in cash and short term investments. This is sufficient to cover its annual cash burn of $80.87M.
  • There are more short-term assets than short-term liabilities on the ALGS balance sheet.

Signs that ALGS is not financially healthy:

  • There are more long-term liabilities than short-term assets on the ALGS balance sheet.
  • ALGS has cash burn of 80873000. It does not have sufficient cash and short-term investments to cover this.
  • Total ALGS debt is still negative.
  • ALGS profit margin has gone down from -564.6% to -3,326% in the past year.
  • ALGS debt to equity ratio of -3.42 is negative.

Is it a good time to buy Aligos Therapeutics stock, according to Wall Street analysts?

Out of 1 sell side analysts who research ALGS, the consensus analyst rating on ALGS is a Buy

It's important to keep in mind that analyst forecasts are not recommendations, nor are they financial advice.

You can dig deeper into what analysts are forecasting on the Aligos Therapeutics stock forecast page.

ALGS Trading Indicators

SMA10
4.61
SMA20
6.61
SMA50
12.6
SMA100
22.16
SMA200
17.01
MACD
-2.44
MACD Signal
-2.73
MACD Histogram
0.29
RSI
27.13
Stochastic %K
16.51
Stochastic %D
15.36
StochRSI %K
88.42
StochRSI %D
75.84

ALGS Growth Numbers

Last year, ALGS revenue was $3.95M. Over the past three year, ALGS's revenue has grown by -45.63% per year. This was slower than the Biotechnology industry average of 44.31%.

Dive into ALGS's earnings and revenue performance here.

Are ALGS insiders buying or selling the stock?

In the past year, insiders at ALGS have not bought or sold any shares.

Dig into more about who owns ALGS shares here.

Does ALGS provide a stable income stream?

No, Aligos Therapeutics doesn't provide an income stream by paying out dividends.

What do other traders have to say about ALGS?

One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to see what other traders have to say.

Step 5: Make your ALGS purchase

You have two primary order types:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are generally fine.
  • Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at an exact dollar amount, use a limit order.

Click the Open Trade button and your broker will place the order.

If you need additional info about buying stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Get the latest scoop on your ALGS investment

Now that you own some shares in ALGS, you'll want to keep up with your new shares.

Put ALGS on a watchlist to get alerted to the latest events about your ALGS stock.

ALGS Feed

How to Buy Stock in Aligos Therapeutics

To summarize, here are the 6 steps to buy stock in Aligos Therapeutics:

  1. Figure out where to buy Aligos Therapeutics stock
  2. Open a brokerage account
  3. Fund your investment account
  4. Evaluate Aligos Therapeutics stock
  5. Make your ALGS purchase
  6. Get the latest scoop on your ALGS investment

If you need a brokerage account, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to keep an eye on your investment in Aligos Therapeutics, add ALGS to your watchlist below.

NASDAQ: ALGS
$4.62-0.06 (-1.28%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: ALGS
$4.62-0.06 (-1.28%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Aligos Therapeutics share?

As of Apr 21, 2025, it costs $4.62 to buy one share of Aligos Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $2, you can buy 0.433 shares of ALGS.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Aligos Therapeutics stock?

According to 1 Wall Street analysts who monitor Aligos Therapeutics, their consensus recommendation is to buy Aligos Therapeutics stock.

What is the best way to buy Aligos Therapeutics stock?

One way to place an order for Aligos Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.